📖 Approx. 9 min
Current Status and Characteristics of Dermatology Clinic M&A
In recent years, M&A within the healthcare industry, particularly for clinic business succession, has been on the rise. Among these, dermatology clinics are attracting attention as M&A targets due to their high specialization and strong affinity with the field of aesthetic medicine. However, M&A of medical institutions differs from general business succession, presenting numerous unique issues such as licenses, medical fees, and the medical corporation system. In cases where aesthetic dermatology services are also offered, more careful consideration is required for valuation and post-acquisition business integration. This article provides a professional perspective on the key valuation points, considerations, and strategies for success for those considering M&A of dermatology clinics.
Valuation Points in Dermatology Clinic M&A
When valuing a dermatology clinic for M&A, it is necessary to analyze not only general business profitability but also medical institution-specific factors from multiple angles. The valuation becomes even more complex when aesthetic dermatology services are integrated.
1. Analysis of Revenue Structure: Insurance vs. Out-of-Pocket Services
The revenue of a dermatology clinic primarily stems from two pillars: insurance-based medical services covered by health insurance, and self-pay services (such as aesthetic dermatology). In M&A, a detailed analysis of the stability, growth potential, and profitability of each revenue stream is essential. For insurance-based services, profitability is assessed by disease and treatment type, based on past medical fee statements andレセプト (receipt) data. For self-pay services, particularly aesthetic dermatology, key evaluation items include the types of procedures offered, pricing, patient acquisition status, and repeat visit rates. Generally, aesthetic dermatology tends to have higher profit margins than insurance-based services, but its revenue sustainability requires attention due to intense competition and rapid trend changes. Acquirers must carefully determine whether they can maintain and grow the existing revenue structure or create synergistic effects.
2. Facility and Equipment Valuation and Future Potential
The clinic’s location, building condition, and the performance and lifespan of medical equipment are also important valuation factors. In particular, the latest aesthetic medical equipment is expensive, and its depreciation and maintenance costs must be considered. Furthermore, based on regional medical plans, the possibility of future patient increases or decreases, and the trends of competing clinics in the vicinity are subject to analysis. Predicting how regional characteristics and demographic changes will affect future revenue is also crucial.
3. Physician and Staff Transition and Organizational Culture
In the M&A of dermatology clinics, physicians, nurses, reception staff, and other personnel are the lifeline for business continuity. The smooth succession of highly specialized physicians and long-serving staff who have built trust with patients is key. Post-acquisition, it is necessary to establish employment conditions and a work environment that maintains the motivation and allows existing staff to utilize their abilities. Additionally, depending on the medical corporation, organizational changes such as the replacement of the representative director or members may occur, requiring consideration of legal procedures and their impact on organizational culture.
Comparative Points in Valuing Clinics with Integrated Aesthetic Dermatology
The presence or absence of aesthetic dermatology significantly impacts clinic valuation. The following table summarizes the comparative points.
| Evaluation Item | Dermatology Clinic (Primarily Insurance-Based) | Dermatology Clinic (with Integrated Aesthetic Services) |
|---|---|---|
| Revenue Stability | Relatively High (due to medical fee system) | Variable, depending on insurance and self-pay services |
| Profit Margin | Standard | Potential to be higher depending on the proportion of self-pay services |
| Patient Acquisition Channels | Word-of-mouth, referrals, community-based | Word-of-mouth, referrals, plus online advertising, social media, influencer marketing, etc. |
| Competitive Environment | Other local clinics | Other clinics, plus aesthetic clinics, beauty salons, etc. |
| Need for Latest Equipment Investment | Depends on disease treatment | Often requires consideration of high-cost aesthetic equipment investment |
| Staff Specialization | Knowledge and experience in dermatological conditions | In addition to dermatological conditions, knowledge and skills in aesthetic procedures, counseling abilities |
Unique Issues in Medical Corporation M&A
M&A involving medical institutions, especially medical corporations, presents several unique issues stemming from their organizational structure. Proceeding without understanding these can lead to unexpected troubles and legal problems.
1. Medical Corporation Types and License Transfer
Medical corporations are broadly categorized into those with equity interests (for-profit medical corporations) and those without (Medical Corporation Without Equity). In the case of non-equity medical corporations, the status of members (shareholders) is not subject to inheritance or transfer; member changes are made according to the articles of incorporation. In contrast, for equity medical corporations, the valuation and transfer procedures for equity interests are complex. In either type, M&A is predicated on obtaining establishment permits for the medical corporation, permits for each medical department, and compliance with various facility standards. Confirming whether these licenses can be smoothly transferred or if re-acquisition is necessary directly impacts post-acquisition business operations.
2. Fund Repayment Adjustments and Off-Balance Sheet Liabilities
Non-equity medical corporations may have established “funds” as an alternative to repaying members’ contributions. During M&A, issues regarding the repayment of these funds can arise. Fund repayment may require substantial funds and can affect the acquisition price. Additionally, the existence of “off-balance sheet liabilities” not apparent on the surface financial statements requires caution. Examples include past unpaid retirement benefits, unpaid expenses under long-term medical equipment maintenance contracts, or potential future litigation risks. Thoroughly identifying these potential liabilities during due diligence (DD) is extremely important.
3. Response to Medical Fee Revisions and Facility Standards
The revenue of medical institutions is heavily influenced by medical fees set by the government. As medical fees are revised periodically, future revision trends must be considered in revenue forecasts post-acquisition. Furthermore, to provide specific medical departments or advanced medical services, “facility standards” set by the Ministry of Health, Labour and Welfare must be met. These facility standards cover a wide range of aspects, including staffing, equipment, and operational methods. Confirming whether the target clinic meets these standards and if they can be maintained or updated post-acquisition is crucial as it directly relates to the calculation of medical fees.
General Step Flow for Medical Corporation M&A
Tax and Legal Considerations
M&A of medical institutions also involves unique tax and legal issues. Understanding these in advance and collaborating with experts leads to smooth transactions and avoidance of future tax risks.
1. Handling of Business Tax and Capital Gains Tax
When a medical corporation transfers its business, the proceeds are generally taxed as “capital gains.” In the case of an equity medical corporation, it involves the transfer of equity interests by members, and income tax (or corporate tax) is levied on the capital gains. When calculating capital gains, acquisition costs and transfer expenses are important. However, for medical corporations, the valuation of intangible assets (brand, customer lists, know-how, etc.) is particularly difficult, often leading to discrepancies between tax-assessed values and actual market values. For non-equity medical corporations, after dissolution and liquidation procedures, any remaining assets are distributed to members, and these distributions are also subject to taxation. Regarding business tax, since the non-profit nature of medical corporations is emphasized, the treatment may differ from that of general business companies. Prior tax simulations by experts are essential.
2. Transfer Procedures for Licenses and Registrations
For medical institutions to continue their operations, it is necessary to ensure that establishment permits issued by public health centers, and various designations (e.g., medical insurance provider, psychiatric emergency medical care system) remain valid and are transferred post-acquisition. Many of these licenses are generally non-transferable, requiring the acquiring party to apply for and obtain new permits. As these procedures take a certain amount of time, it is important to allow ample time in the M&A schedule. Additionally, procedures related to individual qualifications and registrations may be necessary based on laws such as the Physician Law, Dentist Law, and Pharmacist Law.
3. Drafting of Contracts and Risk Allocation
M&A agreements must clearly define a wide range of matters, including the transfer price, payment method, representations and warranties, indemnification, confidentiality obligations, and non-compete clauses. Particularly in medical institution M&A, given the existence of risks such as off-balance sheet liabilities, licensing issues, and fluctuations in medical fees, it is essential to clearly stipulate in the contract which party bears these risks and how. Review of the contract by legal experts such as attorneys is indispensable.
✅ Key Tax and Legal Points for Medical M&A to Know
- Valuation of equity interests and calculation of capital gains tax
- Treatment of fund repayment adjustments
- Existence of off-balance sheet liabilities (unpaid retirement benefits, litigation risks, etc.)
- Transfer/re-acquisition procedures for licenses (establishment permits, facility standards, etc.)
- Impact of medical fee revisions and revenue forecasts
- Clarification of risk allocation in the transfer agreement
Strategies for Successful Dermatology Clinic M&A
To ensure the success of dermatology clinic M&A, meticulous advance planning and collaboration with experts are essential. Especially when aesthetic dermatology is involved, strategies to maximize synergistic effects are crucial.
1. Formulating Clear Acquisition Objectives and Business Plans
First, it is important to clarify the objective: why do you want to acquire the clinic, and what do you aim to achieve through the acquisition? For example, objectives might include expanding regional market share, entering the aesthetic dermatology field in earnest, securing physicians, or utilizing the existing patient base. The strategy will vary depending on the objective. Once the objective is clear, a post-acquisition business plan can be concretely formulated. This involves planning staffing, treatment policies, marketing strategies, and IT system integration, creating a roadmap to maximize acquisition benefits.
2. Utilizing Reliable M&A Advisors
M&A of medical institutions requires specialized knowledge. Utilizing M&A advisors (intermediary companies, consulting firms, etc.) who can accurately understand the multifaceted issues of the medical system, medical fees, medical law, taxation, and legal matters, and provide appropriate advice, is the path to success. It is particularly important to choose advisors with extensive experience in medical M&A. Advisors can support the entire process, from target search and negotiation to due diligence, contract execution, and closing.
3. Thorough Due Diligence (DD)
Due diligence is the process of thoroughly investigating the target clinic’s assets, liabilities, profitability, legal, tax, and labor status to identify potential risks. In medical institution M&A, it is essential to conduct a thorough investigation of unique risks such as licenses, medical fees, funds, and off-balance sheet liabilities, in collaboration with experts (physicians, accountants, tax advisors, lawyers, etc.). Particularly for clinics with integrated aesthetic dermatology services, careful investigation of profitability, future potential, and related regulations (such as the Act against Unjustifiable Premiums and Misleading Representations) is required.
4. Importance of Post-Merger Integration (PMI) Plan
M&A does not end with contract signing and acquisition completion; rather, that is the true beginning. Developing and steadily executing a Post-Merger Integration (PMI) plan is extremely important for maximizing the M&A outcome. Especially when integrating clinics with different organizational cultures and treatment policies, careful communication and the establishment of a system that satisfies both parties’ staff are required. The acquiring party must understand and respect the strengths of the acquired clinic while integrating them with their own strengths.
Dermatology clinic M&A is a highly specialized field that requires navigating numerous issues. However, at M&A Medical, our experts, well-versed in the healthcare industry, can propose optimal M&A strategies tailored to your clinic’s situation. We offer free consultations regarding business succession and M&A, so please feel free to contact us.
Consult M&A Medical for Medical Succession
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the successful transfer of clinics and medical corporations facing successor shortages, as well as strategic acquisitions, on a success-fee basis.
- Initial consultation and preliminary appraisal are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeds under NDA)
- Services available nationwide across all 47 prefectures and all medical specialties
Please consult us early, even in the initial stages of consideration, whether you just want to know the market price, have no successor, or are considering joining a group.